Last reviewed · How we verify
Identification and Characterization of Commercial RUO Antibodies for the Detection of Specific Breast Cancer Tumoral Markers Expressed in Potential Circulating Tumoral Cells (CTCs)
This is an exploratory research study with the aim of identifying specific cancer biomarkers in various subtypes of breast cancer. Blood samples will be collected from 60 participants divided into 40 patients and 20 healthy donors. An amendment to the research has been proposed to enroll 24 additional participants divided into 12 patients and 12 healthy donors.
Details
| Lead sponsor | Tethis S.p.A. |
|---|---|
| Status | ACTIVE_NOT_RECRUITING |
| Enrolment | 84 |
| Start date | 2021-10-04 |
| Completion | 2026-12 |
Conditions
- Breast Neoplasms
Primary outcomes
- Number of commercial Antibodies capable of Identify specific Breast Cancer Biomarkers — 1 day (at the blood draw)
Qualitative Assessment of Staining Positivity for different Breast Cancer Biomarkers
Countries
Italy